Advertisement
Organisation › Details
Proteo Biotech (Group)
The company researches, develops and markets compounds for biological and medical research as well as for use as pharmaceuticals. The main focus is on anti-inflammatory drugs, in particular on the human protease inhibitor Elafin. Proteo intends to out-license selected indications and to establish international strategic alliances in order to open up new fields of application and for marketing (www.proteo.us). *
Start | 2000-01-01 established | |
Group | Proteo Biotech AG | |
Industry | pharmaceutical active protein | |
Region | Kiel | |
Country | Germany | |
Street | 44 Am Kiel-Kanal | |
City | 24106 Kiel | |
Tel | +49-431-8888-462 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top